A group of 340B stakeholders brought a lawsuit on September 11, 2018, against the Department of Health and Human Services (HHS) over the delay in implementing the final rule for drug pricing transparency published in the...more
On November 15, 2017, a bipartisan bill was introduced in the U.S. House of Representatives aimed at preventing CMS from reducing reimbursement by nearly 30 percent for Medicare Part B drugs purchased by certain hospitals...more